REFERENCES

 

 

American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd ed. American Psychiatric Association, Washington.

 

Ånggård E, Gunne LM, Holmstrand J, McMahon RE, Sandberg CG, Sullivan HR (1975) Disposition of methadone in methadone maintenance. Clin Pharmacol Ther 17: 258-266.

 

Ånggård E, Nilsson MI, Holmstrand J, Gunne LM (1979) Pharmacokinetics of methadone during methadone maintenance therapy: pulse labeling with deuterated methadone in the steady-state. Eur J Clin Pharmacol 16: 53-57.

 

Arrindell WA, Ettema H (1981) Dimensionele structuur, betrouwb­aarheid en validiteit van de Nederlandse bewerking van de Symp­tom Checklist (SCL-90); gegevens gebaseerd op een fobische en een 'normale' populatie. Ned T Psychologie 36: 77-108.

 

Arrindell WA, Ettema JHM (1986) SCL-90  Handleiding bij een multidimensionele psychopathologie-indicator. Swets en Zeitlinger, Lisse.

 

Baanders AP (1986) Heroine en jeugd. Criminologisch Instituut, Katholieke Universiteit Nijmegen, Nijmegen.

 

Ball JC (1988) Reducing the risk of AIDS through methadone maintenance treatment. J Health Social Behaviour 29: 214-226.

 

Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer-Verlag, New York.

 

Baselt RC, Casaret LJ (1972) Urinary excretion of methadone in man. Clin Pharmacol Ther 13: 64-70.

 

Beck O, Boreus LO, Lafolie P, Jacobsson G (1991) Chiral analysis of methadone in plasma by high performance liquid chromatography. J Chromatogr 570: 198-202.

 

Beckett AH, Taylor JF, Casy AF, Hassan MMA (1968) The biotransformation of methadone in man: synthesis and identification of a major metabolite. J Pharm Pharmac 20: 754-762.

 

Bell J, Bowron P, Lewis J, Batey R (1990) Serum levels of methadone in maintenance clients who persist in illicit drug use. Brit J Addict 85: 1599-1602.

 

Bell J, Seres V. Bowron P, Lewis J, Batey R (1988) The use of serum methadone levels in patients receiving methadone maintenance. Clin Pharmacol Ther 43: 623-629.

 

Bellward GD, Warren PM, Howard W, Axelson JE, Abbott FS (1977) Methadone maintenance: effect of urinary pH on renal clearance in chronic high and low doses. Clin Pharmacol Ther 22: 92-99.

 

Bryant KJ, Rounsaville BJ, Spitzer RL, Williams JBW (1992) Reliability of dual diagnosis. J Nerv Ment Dis 180, 251-257.

 

Buisman WR (1983) De ontwikkeling van de methadonverstrekking in Nederland. T Alc Drugs 9: 24-29.

 

Caplehorn JR, Bell J, Kleinbaum DG, Gebski VJ (1993) Methadone dose and heroin use during maintenance treatment. Addiction 88: 119-124.

 

Caplehorn JR, Dalton MS, Cluff MC, Petrenas AM (1994) Retention in methadone maintenance and heroin addict's risk of death. Addiction 89: 203-209.

 

Childress AR, McLellan AT, O'Brien CP (1986) Conditioned responses in a methadone population. A comparison of laboratory, clinic, and natural settings. J Subst Abuse Treat 3: 173-179.

 

Craig RJ (1979) Personality characteristics of heroin addicts: a review of the empirical literature with critique-part 2. Int J Addict 14: 607-626.

 

Csikszentmihaly, M, Larson R (1987) Validity and reliability of the experience-sampling method. J Nerv Ment Dis 175: 526-536.

 

De Vos JW, Geerlings PJ, van den Brink W, Ufkes JGR, van Wilgenburg H (1995) Pharmacokinetics of methadone and its primary metabolite in twenty opiate addicts. Eur J Clin Pharmacol 48: 361-366.

 

De Vos JW, van Wilgenburg H, van den Brink W, Kaplan CD, de Vries MW (1996a) Patterns of craving and pharmacokinetics in long-term opiate addicts in methadone maintenance therapy. Addiction Research 3: 285-295.

 

De Vries MW (1987) Investigating mental disorders in their natural settings. J Nerv Ment Dis 175: 509-513.

 

De Vos JW, van den Brink W, Leeuwin RS (1997) Opiate craving and presence of psychopathology. Eur Addict Res, Accepted for publication.

 

De Vos JW, Ufkes JGR, van Brussel GHA, van den Brink W (1996b) Craving despite extremely high methadone dosage. Drug Alcohol Depend 40: 181-184.

 

Delespaul PAEG (1995) Assessing schizophrenia in daily life - the experience sampling method. IPSER Series in Ecological Psychiatry vol.1. Universitaire Pers Maastricht, Maastricht.

 

Denson DD, Concilus RR, Warden G, Prithvi RP (1990) Pharmacokinetics of continuous intravenous infusion of methadone in the early postburn period. J Clin Pharmacol 30: 70-75

Derks J (1990) The efficacy of the the Amsterdam morphine dispensing programme. In: Ghodse H, Kaplan C, Eds.; Drug misuse and dependence. The British and Dutch response. Pantheon Publications: p 75-98.

 

Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 9: 13-27.

 

Derogatis LR (1977) SCL-90: administration, scoring and procedures manual-I for the R(evised) version. John Hopkins University School of Medicine, Clinical Psychometrics Research Unit, Baltimore.

 

Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychol Med 19: 1007-1013.

 

Derogatis, L.R. (1972) SCL-90: Administration, scoring and procedures manual-I for the R(evised) version. John Hopkins University school of Medicine, clinical psychometrics research unit, Baltimore.

 

Docherty JP, Fiester SJ, Shea T (1986) Syndrome diagnosis and personality disorder; in Frances AG, Holes RE (eds): American Psychiatric Association Annual Review vol. 5.  American Psychiatric Press, Washington, DC.

 

Dole VP, Nyswander ME (1965) A medical treatment for diacetylmorphine (heroin) addiction. J Am Med Assoc 193: 646-650.

 

Dole VP (1994) Conversation with Vincent Dole. Addiction 89: 23-29.

 

Done JN, Kennedy GJ, Knox JH (1972) Revolution in liquid chromatography. Nature 237: 77-81.

 

Driessen FMHM (1990) Methadonverstrekking in Nederland. Bureau Driessen, Utrecht.

 

Driessen FMHM (1996) Vermindering van overlast door verstrekking van hoge methadondoses. Voorstel voor een experiment. Bureau Driessen, Utrecht.

 

Eap CB, Cuendet C, Baumann P (1990) Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of  1-acid glycoprotein. Clin Pharmacol Ther 47: 338-346.

 

Eap CB, Finkbeiner T, Gastpar M, Scherbaum N, Powell K, Baumann P (1996) Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics. Eur J Clin Pharmacol 50: 385-389.

 

Edwards G, Arif A, Hodgson R (1981) Nomenclature and classification of drug and alcohol-related problems: A shortened version of a WHO memorandum. Br J Addict 77: 3-20.

 

Fraser HF, Isbell H (1962) Human pharmacology and addictiveness of certain dextroisomers of synthetic analgesics: I. d-3-hydroxy-N-phenethylmorphinan II. d-3-methoxy-N-phenethylmorphinan III. d-methadone. Bull Narcotics 14: 25-35.

 

Gardner MJ, Altman DG (1986) Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 292: 746-750

 

Geerlings PJ (1982) Methadonverstrekking: hoe en waarom? Pharmaceutisch Weekblad 117: 507-513.

 

Gibaldi M, Perrier D (1982) Pharmacokinetics - Drugs and the pharmaceutical sciences. Marcel Dekker, New York

 

Goldberg DP (1972) The detection of psychiatric illness by questionnaire. Oxford University Press, London.

 

Goldberg DP, Hillier VF (1979) A scaled version of the General Health Questionnaire. Psychol Med 9: 139-145.

 

Goldstein A, Hansteen RW, Horns WH (1975) Control of methadone dosage by patients. JAMA 234: 734-737.

 

Gossop M (1994) Verschreibung von Heroin und anderen injizierbaren Drogen an Abhängige aus britischer Sicht. Sucht 5: 325-333.

 

Griffin ML, Weiss RD, Mirin SM, Wilson H, Bouchard-Voelk B (1987) The use of the Diagnostic Interview Schedule in drug-dependent patients. Am J Drug Alcohol Abuse 13: 281-291.

 

Haertzen CA, Meketon MJ (1968) J Nerv Ment Dis 9: 450-455.

 

Hamilton RJ, Sewell PA (1977) Introduction to high performance liquid chromatography. Chapman & Hall, London.

 

Handal PJ, Lander JJ (1976) Methadone treatment: program evaluation and dose response relationships. Int J Addict 11: 363-375.

 

Handelsman L, Cochrane KJ, Aronson MJ, Rubinstein KJ, Kanof PD (1987) Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 13: 293-308.

 

Hargreaves, W.A. (1983) Methadone dosage and duration for maintenance treatment. In: Research on the treatment of narcotic addiction. Ed. JR Cooper. DHHS Publication no. (ADM)97-1281. Washington, DC.

 

Hartgers C, Hoek A van den, Krijnen P, Coutinho RA (1992) HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam. American Journal of Public Health 82: 547-551.

 

Hendriks VM, Kaplan CD, van Limbeek J, Geerlings PJ (1989) The Addiction Severity Index: reliability and validity in a Dutch addict population. J Subst Abuse Treat 6: 133-141.

 

Hendriks VM (1987) Handleiding bij het gebruik van de Addiction Severity Index. Erasmus Universiteit, Rotterdam.

 

Hendriks VM, Steer RA, Platt JJ, Metzger DS (1990) Psychopathology in Dutch and American heroin addicts. Int J Addict 25: 1051-1063.

 

Hiltunen AJ, Lafolie P, Martel J, Ottosson EC, Boreus LO, Beck O, Borg S, Hjemdahl P (1995) Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients. Psychopharmacology 118: 122-126.

 

Holmstrand J, Ånggård E, Gunne LM (1978) Methadone maintenance: plasma levels and therapeutic outcome. Clin Pharmacol Ther 23: 176-180.

 

Horns WH, Rado M, Goldstein A (1975) Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride. Clin Pharmacol Ther 17: 636-649

 

Hovens JE, Hensel RW, Griffioen J (1984) Doelstellingen van methadon programma's; een onderzoek in het veld. T Alc Drugs 10: 19-27.

 

Hubbard, R.L., Marsden, M.E., Fachas, J.V., Harwood, H.J., Cavanaugh, E.R. and Ginzburg, H.M. (1989) Drug abuse treatment: a national study of effectiveness. Chapel Hill: University of North Carolina Press.

 

Inturissi CE, Colburn WA, Kaiko RF, Houde RW, Foley KM (1987) Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 41: 392-401

 

Isbell H, Eisenman AJ (1948) The addiction liability of some drugs of the methadon series. J Pharmacol Exp Ther 93: 305-313.

 

Jacob P, Rigod JF, Pond SM, Benowitz NL (1981) Determination of methadone and its primary metabolite in biologic fluids using gas chromatography with nitrogen-phosphorus detection. J Anal Toxicol 5: 292-295.

 

Jaffe JH (1970) Further experience with methadone in the treatment of narcotics users. Int J Addict 5: 375-389.

 

Jansen PAJ (1982) Potent, new analgesics, tailor-made for different purposes. Acta Anaesth Scand 26: 262-268.

 

Jansen PAJ (1956) A new series of potent analgesics. J Am Chem Soc 78: 3862-3866.

 

Jongerius J, Hull H, Derks J (1994) Hoe scoort de verslavingszorg? NcGv, publicatie nr 94-4, Utrecht.

Judson BA, Horns WH, Goldstein A (1976) Side effects of levomethadone and racemic methadone in a maintenance program. Clin Pharmacol Ther 20: 445-449.

 

Kaplan, C.D. (1992) Drug craving and drug use in the daily life of heroin addicts. In: The experience of psychopathology: Investigating mental disorders in their natural settings (de Vries, M.W., ed.), pp. 193-218. Cambridge University Press, Cambridge.

 

Kell, M.J. (1994) Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting. J Addict Dis 13: 5-26.

 

Khantzian EJ, Treece C (1985) DSM-III Psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 42: 1067-1071.

 

Kintz P, Mangin P, Lugnier AA, Chaumont AJ (1990) A rapid and sensitive gas chromatographic analysis of methadone and its primary metabolite. J Toxicol Clin Exp 10: 15-20.

 

Kintz P, Tracqui A, Mangin P, Lugnier AA, Chaumont AJ. Fatal intoxication by dextromoramide: a report on two cases. J Anal Toxicol 1989; 13: 238-239.

 

Koeter MWJ, Ormel J (1992) General Health Questionnaire: Nederlandse bewerking. Handleiding. Swets en Zeitlinger, Lisse.

 

Koeter MWJ (1992) Valididty of the GHQ and SCL anxiety and depression scales: A comparative study. J Affect Dis 24: 271-280.

 

Kozlowski LT, Wilkinson DA (1987) Use and misuse of the concept of craving by alcohol, tobacco, and drug researchers. Br J Addict 82: 31-36.

 

Kreek MJ, Bencsath FA, Field FH (1980) Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: quantitation by direct probe chemical ionization mass spectrometry. Biomed Mass Spectrometry 7: 385-395.

 

Kreek MJ, Hachey DL, Klein PD (1979) Stereoselective disposition of methadone in man. Life Sci 24 :925-932.

 

Kristensen K, Angelo HR (1992) Stereospecific gas chromatographic method for determination of methadone in serum. Chiralty 4: 263-267.

 

Kristensen K, Christensen CB, Christup LL (1995) The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 56: PL45-50.

 

Kristensen K, Blemmer T, Angelo HR, Christup LL, Drenck, Rasmussen SN, Sjøgren (1996) Stereoselective pharmacokinetics of methadone in chronic pain patients. Ther Drug Monit 18: 221-227.

 

Lançon JP, Pechinot A, Athis PD, Pechinot M, Pointaire P, Obadia JF, Caillard B (1989) Pharmacocinétique du dextromoramide chez l'opéré. Ann Fr Anesth Réanim 8: 488-492.

 

Lang F (1994) Zur umstellung van Polamidon auf Methadon. Berliner Tinke Magazin No. 5: 4-6.

 

Larson R, Csikszentmihalyi M, Freeman M (1992) Alcohol and marijuana use in adolescents' daily lives. In: The experience of psychopathology: Investigating mental disorders in their natural settings. Ed. MW de Vries. Cambridge University Press, Cambridge.

 

Lehman WEK, Barrett ME, Simpson DD (1990) Alcohol use by heroin addicts 12 years after drug abuse treatment. J Stud Alcohol 51:  233-244.

 

Liefhebber J (1979) Methadonverstrekking in Nederland, een poging tot inventarisatie. T Alc Drugs 5: 124-130.

 

Ling W, Rawson RA, Compton MA (1994) Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. J Psychoact Drugs 26: 119-128.

 

Loimer N, Linzmayer L, Grünberger J (1991) Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification. Drug Alcohol Depend 28: 265-268.

 

Loimer N, Schmid R (1992) The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Depend 30: 241-246.

 

Maddux JF, Esquivel M, Vogtsberger KN, Desmond DP (1991) Methadone dose and urine morphine. J Subst Abuse Treat 8: 195-201.

 

Maremmani I, Zolesi O, Agueci T, Castrogiovanni P (1993) Methadone doses and psychopathological symptoms during methadone maintenance. J Psychoact Drugs 25: 253-256.

 

Maremmani I, Nardini R, Zolesi O, Castrogiovanni P (1994) Methadone dosages and therapeutic compliance during a methadone maintenance program. Drug Alcohol Depend 34: 163-166.

 

McCarthy JJ, Borders OT (1985) Limit setting on drug abuse in methadone maintenance patients. Am J Psychiatry 142: 1419-1423.

 

McGahan P, Griffith J, McLellan AT (1986) Composite scores from the Addiction Severity Index: Manual and computer software. Veterans Administration Press, Philadelphia, PA.

 

McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M (1992) The fifth edition of the Addiction Severity Index: Historical critique and normative data. J Subst Abuse Treat 9: 199-213.

Meresaar U, Nilsson MI, Holmstrand J, Ånggård E (1981) Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method. Eur J Clin Pharmacol 20: 473-478

 

Minjon B (1994) Entwicklungen in Amsterdam: eine experimentelle Studie mit der Vergabe von Palfium. Sucht 5: 340-341.

 

Mirin SM, Weiss RD, Griffin ML, Michael JL (1991) Psychopathology and mood during heroin use. Arch Gen Psychiatry 33: 1503-1508.

 

Mol R, Otter E, van der Gouwe D (1993) Belangen van druggebruikers. Uitgangspunten en doelstellingen Belangenvereniging Druggebruikers MDHG. Tweejarenverslag 1991 en 1992. MDHG, Amsterdam.

 

Nakamura K, Hachey DL, Kreek MJ, Irving CS, Klein PD (1982) Quantitation of methadone enantiomers in humans using stable isotope-labeled [2H3]-, [2H5]-, and [2H8]methadone. J Pharm Sci 71: 40-43.

 

Nilsson MI, Ånggård E, Holmstrand J, Gunne LM (1982) Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the inductive phase. Eur J Clin Pharmacol 22: 343-349.

 

Nilsson MI, Grönbladh L, Widerlöv E, Ånggård E (1983) Pharmacokinetics of methadone maintenance treatment: characterization of therapeutic failures. Eur J Clin Pharmacol 25: 497-501.

 

Nilsson MI, Widerlöv E, Meresaar U, Ånggård E (1982) Effect of urinary pH on the disposition of methadone in man. Eur J Clin Pharmacol 22: 337-342.

 

Norusis MJ (1988) SPSS-PC plus base manual. SPSS, Chicago.

 

Novick DM, Kreek MJ, Fanizza AM, Yancovitch SR, Gelb AM, Stenger RJ (1981) Methadone disposition in patients with chronic liver disease. Clin Pharmacol Ther 30: 353-362.

 

O'Brien CP, Childress AR, McLellan AT, Ehrman R (1992) A learning model of addiction. In: Addictive States (O'Brien, C.P.O. and Jaffe, J.H., eds.), pp. 157-177. Raven Press, New York.

 

Olsen GD, Wendel HA, Livermore JD, Leger RM, Lynn RK, Gerber N (1976) Clinical effects and pharmacokinetics of racemic methadone and its optical isomers. Clin Pharmacol Ther 21: 147-157.

 

Olsen GD, Wilson JE, Robertson GE (1981) Respiratory and ventilatory effects of methadone in healthy women. Clin Pharmacol Ther 29: 373-380

 

Ormel J, Koeter MWJ, van den Brink W, Giel R (1989) Concurrent validity of GHQ-28 and PSE as measures of change. Psychol Med 19: 1007-1013.

 

Pagani I, Barzaghi N, Crema F, Perucca E, Ego D, Rovei V (1989) Pharmacokinetics of dextromoramide in surgical patients. Fundam Clin Pharmacol 3: 27-35.

 

Parrino MW, Consensus Panel Chair (1993) State methadone treatment guidelines. Treatment Improvement Protocol (TIP) Series. DHHS Publication no. (SMA) 93-1991. Rockville, MD.

 

Pierce TL, Murray AGW, Hope W (1992) Determination of methadone and its metabolites by high performance liquid chromatography following solid-phase extraction in rat plasma. J Chromat Sci 30: 443-447.

 

Plummer JL, Gourlay GK, Cherry DA, Cousins MJ (1988) Estimation of methadone clearance: application in the management of cancer pain. Pain 33: 313-322.

 

Pohland A, Boaz HE, Sullivan HR (1971) Synthesis and identification of metabolites resulting from the biotransformation of dl-methadone in man and in rat. J Medicinal Chem 14: 194-197.

 

Powell J, Bradley B, Gray J (1992) Classical conditioning and cognitive determinants of subjective craving for opiates: an investigation of their relative contributions. Br J Addict 87: 1133-1144.

 

Powell J (1995) Conditioned responses to drug-related stimuli: Is context crucial? Addiction 90: 1089-1095.

 

Proost JH, Meijer DKF (1992) MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med 22: 155-163.

 

Reilly PJ, Suann CJ, Duffield AM (1990) Gas chromatographic-mass spectrometric investigation of dextromoramide (Palfium) metabolism in the horse. J Chromatogr 498: 35-40.

 

Robins LN, Helzer JE, Croughan S, Kathryn S, Ratcliff KS (1981) National Institute of Health Diagnostic Interview Schedule. Arch Gen Psychiatry 38: 381-389.

 

Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive sensitization theory of addiction. Brain Research Reviews 18, 247-291.

 

Romach MK, Piafsky KM, Abel JG, Khouw V, Sellers EM (1981) Methadone binding to oromucoid (1-acid glycoprotein): determinant of free fraction in plasma. Clin Pharmacol Ther 29: 211-217.

 

Roszell DK, Calsyn DA (1986) Methadone dosage: patient characteristics and clinical correlates. Int J Addict 21: 1233-1246.

 

Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H (1982) Diagnosis and symptoms of depression in opiate addicts. Arch Gen Psychiatry 39: 151-156.

Rounsaville BJ, Weissman MM, Rosenberger PH, Wilber CH, Kleber HD (1979) Detecting depressive disorders in drug abusers: A comparison of screening instruments. J Affect Dis 1: 255-267.

 

Rounsaville BJ, Kosten TR, Weissman MM, Prusoff B, Pauls D, Anton SF, Merikangas K (1991) Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry 48: 33-42.

 

Saß H (1991) Pro und Contra: Substitution Drogenabhängiger mit Methadon. Nervenarzt 62: 521-523.

 

Säwe J, Hansen J, Ginman C, Hartvig P, Jakobsson PA, Nilsson MI, Rane A, Ånggård E (l981) Patient-controlled dose regimen of methadone for chronic cancer pain. Brit Med J 282: 771-779

 

Scott CC, Robbins EB, Chen KK (1948) Pharmacologic comparison of the optical isomers of methadone. J Pharmacol Exp Ther 93: 282-286.

 

Seymour-Shove R, Wilson CW (1967) Dependence on dextromoramide. Brit Med J 1: 88-90.

 

Simpson, D.D. and Sells, S.B. (1982) Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol and Substance Abuse 2: 7-29.

 

Staib AH, Krause JKA, Tursch M, Lang P, Hellenbrecht D (1995) Comparison of the therapeutic outcome of racemic vs. levomethadone in a methadone maintenance therapy program - a double-blind study. Arch Pharmacol  351: Suppl. R17, A67.

 

Staib AH, Fuhr U, Krause JKA, Tursch M, de Vos JW, van Wilgenburg H, Ufkes JGR, Hellenbrecht D (1995) Racemic vs. Levo-Methadone for maintenance in opiate addicts. Thérapie 50: Suppl. 1, abstracts 1st congress of EACPT No.364.

 

Stitzer ML, Bickel WK, Bigelow GE (1986) Altered dose incentive procedures: Effects on polydrug use among methadone maintenance patients: in Harris LS (ed): Problems of Drug Dependence. National Institute on Drug Abuse, Rockville, Maryland.

 

Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993b) Methadone dose and treatment outcome. Drug Alcohol Depend 33: 105-117.

 

Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1993a) Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med 119: 23-27.

 

Sullivan HR, Smits SE, Due SL, Booher RE, McMahon RE (1972) Metabolism of d-methadone: isolation and identification of analgesically active metabolites. Life Sci 11: 1093-1104.

 

Sullivan HR, Due SL, McMahon RE (1975) The difference in activity between (+)- and (-)-methadone is intrinsic and not due to a difference in metabolism. J Pharm Pharmacol 27: 728-732.

 

Sullivan HR, Due SL (1973) Urinary metabolites of dl-methadone in maintenance subjects. J Med Chem 16: 909-913.

 

Tennant FS Jr., Rawson RA, Cohen A, Tarver A, Clabough D (1984) Methadone plasma levels and persistent drug abuse in high dose maintenance patients. NIDA Res Monogr 49: 262-268.

 

Tennant FS Jr, Rawson RA, Cohen A, Tarver A, Clabrough D. (1983) Methadone plasma levels and persistent drug use in high-dose methadone patients. Subst Alcohol Actions Misuse 4: 369-374.

 

Treece CD, Nicholson B (1980) DSM-III personality type and dose levels in methadone maintenance patients. J Nerv Ment Dis 168: 621-628.

 

van de Wijngaard G (1991) Competing perspectives on drug use: the Dutch experience. Swets & Zeitlinger, Amsterdam.

 

van de Wijngaart G, Verbraeck H (1990) Methadone in de jaren negentig. WGU-Cahier 12, Preventieproject Alcohol en Drugs Rijksuniversiteit Utrecht, Utrecht.

 

van Brussel GHA, van Lieshout SJM (1993) Jaarverslag 1992 drugsafdeling. Gemeentelijke Geneeskundige en Gezondheidsdienst Amsterdam Sector GGZ, Drugsafdeling, Amsterdam.

 

van Limbeek J, Schalken HFA, Geerling PJ, Wouters L, de Groot PA, Sijlbing G, Beelen W (1986) Het gebruik van het Diagnostisch Interview Schema (DIS) bij het vaststellen van psychopathologie bij alcohol- en drugverslaafden. T Alc Drugs 28: 459-474.

 

van Limbeek J, Wouters L, Kaplan CD, Geerlings PJ, van Alem V (1992) Prevalence of psychopathology in drug-addicted dutch. J Subst Abuse Treat 9: 43-52.

 

van Brussel GHA, Buster MCA, Woude DH van der (1996) Dovend vuur: Jaarbericht 1994-1995 Drugsafdeling GG&GD. GG&GD, Amsterdam.

 

van Brussel GHA, van der Woude DH, Lieshout SJM (1994) Werkt het Amsterdamse sociaal-medische drugshulpbeleid? Jaarbericht van de Drugsafdeling GG&GD waarin opgenomen de jaarcijfers '93. Gemeentelijke Geneeskundige en Gezondheidsdienst, Amsterdam.

 

van Brussel GHA, van Lieshout SJM (1993) Jaarverslag 1992 drugsafdeling. Gemeentelijke Geneeskundige en Gezondheidsdienst Amsterdam, Amsterdam.

 

Verebely K, Volavka J, Mulé S, Resnick R (1975) Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharmacol Ther 18: 180-190.

Walsh TD (1983) In: Methods of morphine estimation in biological fluids and the concept of free morphine. Ed. JFB Stuart. Royal Society of Medicine, London.

 

Wang, R.I.H., Wiesen, R.L., Lamid, S. and Roh, B.L. (1974) Rating the presence and severity of opiate dependence. Clin Pharmacol Ther 16: 653-658.

 

Weissman MM, Slobetz F, Prusoff B, Mezritz M, Howard P (1976) Clinical depression among narcotic addicts maintained on methadone in the community. Am J Psychiatry 133: 1434-1438.

 

Whitehead CC (1974) Methadone pseudowithdrawal syndrome: paradigm for a psychopharmacological model of opiate addiction. Psychosom Med, 36, 189-198.

 

Wikler A (1973) Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatr 28: 611-616.

 

Wolff K, Sanderson M, Hay AWM, Raystrick D (1991) Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem 37: 205-209.

 

Wolff K, Hay AWM, Raistrick D, Calvert R (1993) Steady-state pharmacokinetics of methadone in opioid addicts. Eur J Clin Pharmacol 44: 189-194.

 

Wolff K, Hay AW (1994) Plasma methadone monitoring with methadone maintenance treatment. Drug Alcohol Depend 36: 69-71.